Compare Stocks

VAALCO Energy, Inc., an independent energy company, engages in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids in Gabon, Egypt, Equatorial Guinea, and Canada. The company holds 58.8% interest in the Etame production sharing contract related to the Etame Marin block covering an area of approximately 46,200 gross acres located offshore in the Republic of Gabon in West Africa. It also owns 100% interest in the Eastern Desert, which contains West Gharib, West Bakr and North West Gharib merged concessions covering as area of approximately 45,067 acres, as well as Western Desert, which contains the South Ghazalat concession covering as area of approximately 7,340 acres located in Egypt. In addition, the company production and working interests in Cardium light oil and Mannville liquids-rich gas assets covering as area of 47,400 gross acres located near the north of Calgary, Alberta; and an undeveloped block offshore Equatorial Guinea, West Africa. VAALCO Energy, Inc. was incorporated in 1985 and is headquartered in Houston, Texas.

Pond Technologies Holdings Inc, formerly Ironhorse Oil & Gas Inc, is a Canada-based company that offers an algae growing platform, which converts carbon dioxide (CO2) into algal-based commercial products. As a pollution abatement technology, Pond Technologies Holdings Inc's algae growing platform converts the CO2 found in the untreated stack gas of industrial emitters into biofuels, animal feeds and natural fertilizers. For the Nutraceutical Market, Pond Technologies Holdings Inc's algae-growing platform transforms food-grade CO2 into algae strains such as Chlorella, Spirulina and Astaxanthin, all of which are used as health food additives and supplements. The Company partners with Saint Mary's Cement and the National Research Council of Canada to show that algae can be used to eliminate the greenhouse gas emissions from industrial facilities, transforming these emissions into bioproducts including biofuels, fertilizers, and animal feeds.

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Painted Pony Energy Ltd. engages in the exploration, development, and production of petroleum and natural gas resources in Western Canada. It focuses primarily on the development and production of natural gas and natural gas liquids from the Montney formation in northeast British Columbia. The company was formerly known as Painted Pony Petroleum Ltd. and changed its name to Painted Pony Energy Ltd. in May 2017. Painted Pony Energy Ltd. is headquartered in Calgary, Canada.